ArticleACS central science2024

Aptamer-Based Nongenetic Reprogramming of CARs Enables Flexible Modulation of T Cell-Mediated Tumor Immunotherapy.

Qiang Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.